83
Participants
Start Date
May 30, 2023
Primary Completion Date
July 1, 2028
Study Completion Date
July 1, 2028
Belantamab mafodotin
Cycles 1, 3, 5, 7, etc. (odd numbered cycles): 1.9 mg/kg IV on Day 1 (28-day cycles)
Carfilzomib
"Cycle 1: 20 mg/m2 on Day 1, then 56 mg/m2 on Days 8/15~Cycles 2-8: 56 mg/m2 on Days 1/8/15~Cycles 9+: 56 mg/m2 on Days 1/15"
Pomalidomide
3 mg Day 1-21 of 28-day Cycle
Dexamethasone
"Cycles 1-4: 40 mg Days 1/8/15/22~Cycles 5+: 20 mg Days 1/8/15/22"
RECRUITING
University of Chicago Medicine Comprehensive Cancer Center, Chicago
Collaborators (2)
GlaxoSmithKline
INDUSTRY
Amgen
INDUSTRY
University of Chicago
OTHER